News

Garry A. Neil to Lead Presentations at Notable Investor Events

Garry A. Neil to Lead Presentations at Notable Investor Events

Garry A. Neil to Speak at Upcoming Investor Conferences

Avalo Therapeutics, Inc. (NASDAQ: AVTX) is making headlines with its participation in significant investor conferences slated for the coming months. The spotlight will be on Garry A. Neil, M.D., the Chief Executive Officer and Chairman of the Board, who is set to share insights and significant developments regarding the company’s innovative approaches to treating immune dysregulation.

Details of the Conferences

The first event is the highly anticipated Stifel 2024 Healthcare Conference, where Dr. Neil will present on Monday, November 18, 2024, at 3:35 PM ET. Following that, he will also take part in the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 5, 2024, at 11:00 AM ET.

Accessing the Presentations

For those unable to attend these conferences in person, Avalo Therapeutics will offer live webcasts featuring Dr. Neil’s presentations. Interested parties can find the webcasts and replays in the Investors section under "News / Events" on the Avalo Therapeutics website. These archived sessions will be accessible for a minimum of 30 days, ensuring that stakeholders can stay informed about Avalo's progress and insights.

About Avalo Therapeutics and Its Mission

Avalo Therapeutics, founded with a primary focus on clinical stage biotechnology, is dedicated to advancing treatments for immune dysregulation. At the forefront of Avalo's research is its lead asset, AVTX-009, a groundbreaking anti-IL-1? monoclonal antibody designed to combat inflammatory diseases.

Innovative Therapeutics

Avalo Therapeutics' product lineup includes innovative drug candidates such as quisovalimab (an anti-LIGHT mAb) and AVTX-008 (a BTLA agonist fusion protein). These candidates aim to provide targeted solutions for patients suffering from various autoimmune and inflammatory conditions.

Understanding AVTX-009

AVTX-009 stands out as a humanized monoclonal antibody with specific affinity for interleukin-1? (IL-1?), a pivotal molecule in the inflammation cascade. Elevated or poorly regulated levels of IL-1? are linked to numerous autoimmune and inflammatory diseases. By inhibiting IL-1? activity, AVTX-009 may offer therapeutic benefits for conditions such as hidradenitis suppurativa, among others in the fields of dermatology, gastroenterology, and rheumatology.

Inquiries for Investors and Media

For any inquiries regarding investor relations or media questions, Christopher Sullivan, CFO of Avalo Therapeutics, is available for contact. Interested individuals can reach out via email or phone, with his contact details provided: ir@avalotx.com and 410-803-6793.

Additionally, inquiries can also be directed to Meru Advisors, represented by Lauren Glaser, at lglaser@meruadvisors.com.

Frequently Asked Questions

What is Avalo Therapeutics known for?

Avalo Therapeutics is a clinical stage biotechnology company focusing on treatments for immune dysregulation, particularly through its innovative drug candidates.

Who will present at the investor conferences?

Dr. Garry A. Neil, the CEO and Chairman of Avalo Therapeutics, will lead the presentations at the upcoming healthcare conferences.

When are the upcoming conferences?

The Stifel 2024 Healthcare Conference is scheduled for November 18, 2024, and the Piper Sandler 36th Annual Healthcare Conference will take place on December 5, 2024.

How can I access the conference presentations?

The live webcasts and replays of the presentations will be available on the Avalo Therapeutics website under the Investors section.

What is AVTX-009?

AVTX-009 is a humanized monoclonal antibody that targets interleukin-1?, which plays a significant role in the inflammatory process related to various autoimmune and inflammatory diseases.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Quay Dominates 2026 Sunglasses Review for Variety

Updated Category News Views 4

Sunglasses Designed for Every Face Type When it comes to picking the right pair of shades, face shape is only part of the equation. Expert Consumers just dropped their 2026 verdict, spotlighting Quay as the go-to brand for those wider faces, tricky nose bridges, and the noggins that run a tad larger than average. Forget what you heard about one-size-fits-all. This...

Continue Reading
BarrelPick.com Launches for Bourbon Aficionados

Updated Category News Views 4

Just when you think you've seen all the ways to enjoy bourbon, along comes BarrelPick.com with a tantalizing new proposition. They're throwing down the gauntlet for bourbon lovers everywhere by letting you buy an entire barrel, let it sit around for a bit, watch it mature, and then call the shots on when it finally sees the light of day in a bottle. Talk about skipping...

Continue Reading
Xi Jinping Thought: A Bold Prospect for Future Governance

Updated Category News Views 5

107 years in the game, and the Communist Party of China (CPC) isn't showing any signs of slowing. With their recent conference in Beijing focusing on Xi Jinping Thought on Party Building, it’s clear they’ve got their eyes on the future, not just resting on past laurels. This Xi Jinping Thought is about a thorough self-improvement plan for the Party, a clear strategy...

Continue Reading
GAC's Cambodia Plant: A Strategic Manufacturing Shift

Updated Category News Views 3

Setting the Stage for New Industrial Growth On September 17, a milestone was etched in the sands of Cambodia when the GAC Cambodia KD Plant officially flipped the switch. This ain't just another factory throwing doors open; it's a fresh chapter in regional manufacturing power plays. We had some big hitters in attendance, like Cambodian Prime Minister Hun Manet, showing...

Continue Reading
China's Tech Success Echoes in Global Living Rooms

Updated Category News Views 4

A New Player in Global Tech If you've been sleeping on China's tech scene, it's time to wake up. Moonshot AI just launched Kimi K3, the largest open-source model by parameters we've seen, a significant leap in artificial intelligence that's catching even the eyes of folks who hardly touch technology—like retirees in Italy. Rapid AI Advancements China's story isn't about...

Continue Reading
Insta360 Expands with Times Square Flagship Store

Updated Category News Views 6

Insta360 Times Square Opening Marks Bold Expansion I dropped by Times Square today, and what do I see? Insta360 planting its flag right in the heart of New York City. Now, this isn't your run-of-the-mill grand opening—it’s the first flagship store outside of Asia, and it screams of big ambitions. Nestled at 1515 Broadway, the store is smack in the middle of one of the...

Continue Reading
Beta Bionics Lawsuit Deadline: Investors Face November 3 Cut-off

Updated Category News Views 5

Looming Deadline for Beta Bionics Investors Time's ticking fast for those holding onto Beta Bionics (BBNX) stock who might've been caught in a web of undisclosed risks and regulatory misses. Investors feeling the pinch from this fiasco have till November 3, 2026, to throw their hat in the ring as lead plaintiffs in the class action lawsuit out of California. The...

Continue Reading
Fast Guard Elevates Nationwide Fire Watch Mission

Updated Category News Views 2

Fast Guard: The Unseen Shield Behind Property Safety Hollywood, Florida might be best known for its sun-kissed beaches, but in the world of fire safety, it’s the nerve center for emergency fire watch response. Fast Guard Service isn’t just any run-of-the-mill security outfit; it’s rapidly becoming the unsung hero of property managers across the nation. When those...

Continue Reading
PayPal Under Investigation: Legal Battles Intensify

Updated Category News Views 3

A Bumpy Ride for PayPal's Investors Back in 2025, PayPal was beaming about new growth strategies, filling the air with grandiose promises. Fast forward to February 2026, and the script had flipped entirely. Earnings came in nasty and disappointing, particularly in the Branded Checkout front. Adding to the chaos was their CEO unceremoniously taking the high road out the...

Continue Reading
Flying Car Regulatory Sandbox Begins in UAE

Updated Category News Views 7

Pioneering Flying Cars in the Desert In a move that seems right out of a science fiction screenplay, ARIDGE—the bigwig of flying cars from Asia—has taken a giant leap. They’ve cozied up with the UAE, locking arms to cook up the world's first regulatory sandbox for personal flying cars. Now, don’t laugh—sandbox isn't just for toddlers. It’s the playground where...

Continue Reading

Top 5 Most Recently Viewed Articles

Class Action Lawsuit Against Allarity Therapeutics: Key Updates

Updated Category News Views 54

Class Action Lawsuit Update for Allarity Therapeutics, Inc. Allarity Therapeutics, Inc. is currently facing a securities class action lawsuit that affects many investors. This important legal case is taking place in the United States District Court, drawing attention to the company's actions during a specific time frame. Details of the Class Action Lawsuit Investors who...

Continue Reading
Artisight Introduces Innovative Voice-Activated Interpreters

Updated Category News Views 219

Artisight's New Voice-Activated Interpreter Feature Artisight has taken a significant step forward in improving healthcare communication by launching its Voice-Activated Interpreter feature on the Smart Hospital Platform. This innovative technology allows clinicians to engage with patients in numerous languages effortlessly. With a simple voice command, healthcare...

Continue Reading
Rigetti Computing Showcases Strong Q1 2025 Performance Metrics

Updated Category News Views 1209

Rigetti Computing Highlights Impressive Q1 2025 Performance Rigetti Computing, Inc. (Nasdaq: RGTI) is on an impressive trajectory, recently reporting its financial results for the first quarter of 2025, showcasing its ongoing advancements in the realm of quantum-classical computing technology. Financial Performance Overview Here are the key highlights from Rigetti's...

Continue Reading
Transforming the Cannabis Experience: The Flavorizers Revolution

Updated Category News Views 902

Revolutionizing Cannabis Consumption Relavor BioPharmaceutical Labs, a pioneering name in the cannabis and medical aerosol sectors, has recently introduced a groundbreaking product called Flavorizers. This extraordinary innovation is designed to transform the way cannabis flower vapor is consumed, setting itself apart in a booming multi-billion dollar market. Introducing...

Continue Reading
Protect Pharmaceutical Corp. Terminates KARINCA Logistics Merger

Updated Category News Views 91

Protect Pharmaceutical Corp. Announces Termination of Merger Protect Pharmaceutical Corp. (OTC: PRTT) has announced that its planned merger with KARINCA Logistics will not move forward. This decision came after a thorough review during the final stages of the due diligence process, where unexpected business challenges were identified. Management's Dedication to...

Continue Reading